Skip to main content

Advertisement

Log in

The clinical utility of assessment of the axilla in women with suspicious screen detected breast lesions in the post Z0011 era

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Axillary ultrasound (AUS) and biopsy are now part of the preoperative assessment of breast cancer based on the assumption that any nodal disease is an indication for axillary clearance (AC). The Z0011 trial erodes this assumption. We applied Z0011 eligibility criteria to patients with screen detected cancers and positive axillary assessment to determine the relevance of AUS to contemporary practice. Women screened between 1/1/2012 and 30/6/2013 and assessed for lesions with highly suspicious imaging features are included. We analysed demographic and assessment data and ascertained the final histopathology with particular reference to axillary nodal status. Among 449 lesions, AUS was recorded in 303 lesions (67.5 %). 290 (96 %) were carcinomas, 30.3 % with nodal disease. AUS was abnormal in 46 (15.9 %). AUS had a sensitivity of 39.8 %, specificity 94.6 %, positive predictive value (PPV) 79.2 % and negative predictive value (NPV) 78.1 %. Axillary FNAB was positive in 27 women, suspicious in two, benign in 16 and not performed in one. In one FNA positive case, the lesion was a nodular breast primary in the axillary tail in a multifocal breast cancer. Combining AUS and FNAB, the sensitivity was 76.5 %, specificity 90.9 %, PPV 96.3 % and NPV 55.6 %. Applying the Z0011 inclusion criteria, 24 of the 27 (88.9 %) women with abnormal AUS and positive FNA were ineligible for Z0011-based management. Of three women eligible for Z0011, one proceeded to AC after SN biopsy, leaving only two women (7.4 %) who might have been considered for SN only management had it not been for the results of the axillary assessment. Among women with negative AUS, nodal metastasis was demonstrated in 21.7 %, 86.8 % of these women having only 1–2 positive nodes. Abnormal AUS and FNA preferentially identify candidates for AC. Negative AUS predicts negative or low nodal burden. Axillary assessment streamlines care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Boughey JC, Moriarty JP, Degnim AC, Gregg MS, Egginton JS, Long KH (2010) Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer. Ann Surg Oncol 17(4):953–958

    Article  PubMed Central  PubMed  Google Scholar 

  2. BASO AoBsa (2009) Surgical guidelines for the management of breast cancer. Eur J Surg Oncol 35(Suppl 1):1–22

    Google Scholar 

  3. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569–575

    Article  CAS  PubMed  Google Scholar 

  4. Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703–7720

    Article  PubMed  Google Scholar 

  5. Farshid G, Rush G (2004) Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer. Am J Surg Pathol 28(12):1626–1631

    Article  PubMed  Google Scholar 

  6. National Breast Cancer Centre (2002) Breast imaging: a guide for practice. National Breast Cancer Centre, Camperdown

    Google Scholar 

  7. BreastScreenAustralia (2005) BreastScreen Australia national accreditation handbook. Commonwealth of Australia, Canberra

    Google Scholar 

  8. Gooch J, King TA, Eaton A et al (2014) The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1–T2 breast cancer. Ann Surg Oncol 21(9):2897–2903

    Article  PubMed  Google Scholar 

  9. Straver ME, Meijnen P, van Tienhoven G et al (2010) Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol 28(5):731–737

    Article  PubMed Central  PubMed  Google Scholar 

  10. Giuliano AE (2013) Reply to letter: are the standard tangential breast irradiation fields used in the ACOSOG Z0011 trial really covering the entire axilla? Ann Surg 257(1):e2

    Article  PubMed  Google Scholar 

  11. Gatzemeier W, Mann GB (2013) Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)–ACOSOG Z0011 results and beyond. Breast 22(3):211–216

    Article  PubMed  Google Scholar 

  12. Robinson KA, Pockaj BA, Wasif N, Kaufman K, Gray RJ (2014) Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection? Am J Surg 208:1060–1064

    Article  PubMed  Google Scholar 

  13. Caretta-Weyer H, Greenberg CG, Wilke LG et al (2013) Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis. Ann Surg Oncol 20(13):4145–4152

    Article  PubMed  Google Scholar 

  14. Ainsworth RK, Kollias J, LeBlanc A, DeSilva P (2013) The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial—results from the BreastSurgANZ National Breast Cancer Audit. Breast 22(5):733–735

    Article  PubMed  Google Scholar 

  15. Yamashita M, Hovanessian-Larsen L, Sener SF (2013) The role of axillary ultrasound in the detection of metastases from primary breast cancers. Am J Surg 205(3):242–244; discussion 44-5

    Article  PubMed  Google Scholar 

  16. Schipper RJ, van Roozendaal LM, de Vries B et al (2013) Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value? Breast 22(6):1108–1113

    Article  CAS  PubMed  Google Scholar 

  17. Nath J, Sami N, Massey J, Donnelly J, Corder AP (2013) Selection for axillary clearance in breast cancer (ultrasound negative, sentinel node positive patients have low rates of further metastases). Eur J Surg Oncol 39(5):450–454

    Article  CAS  PubMed  Google Scholar 

  18. Abe H, Schacht D, Sennett CA, Newstead GM, Schmidt RA (2013) Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer. AJR Am J Roentgenol 200(3):696–702

    Article  PubMed  Google Scholar 

  19. Verheuvel NC, van den Hoven I, Ooms HW, Voogd AC, Roumen RM (2014) The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era. Ann Surg Oncol 22:409–415

    Article  PubMed  Google Scholar 

  20. Choi JS, Kim MJ, Moon HJ, Kim EK, Yoon JH (2012) False negative results of preoperative axillary ultrasound in patients with invasive breast cancer: correlations with clinicopathologic findings. Ultrasound Med Biol 38(11):1881–1886

    Article  PubMed  Google Scholar 

  21. Ibrahim-Zada I, Grant CS, Glazebrook KN, Boughey JC (2013) Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery. J Am Coll Surg 217(1):7–15; discussion 15-6

    Article  PubMed Central  PubMed  Google Scholar 

  22. Galimberti V, Cole BF, Zurrida S et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14(4):297–305

    Article  PubMed Central  PubMed  Google Scholar 

  23. Bochner MA, Farshid G, Dodd TJ, Kollias J, Gill PG (2003) Intraoperative imprint cytologic assessment of the sentinel node for early breast cancer. World J Surg 27(4):430–432

    Article  PubMed  Google Scholar 

  24. Peg V, Espinosa-Bravo M, Vieites B et al (2013) Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients. Breast Cancer Res Treat 139(1):87–93

    Article  CAS  PubMed  Google Scholar 

  25. Diepstraten SC, Sever AR, Buckens CF et al (2014) Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis. Ann Surg Oncol 21(1):51–59

    Article  PubMed  Google Scholar 

  26. Houssami N, Ciatto S, Turner RM, Cody HS III, Macaskill P (2011) Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg 254(2):243–251

    Article  PubMed  Google Scholar 

  27. Lee B, Lim AK, Krell J et al (2013) The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancer. AJR Am J Roentgenol 200(3):W314–W320

    Article  PubMed  Google Scholar 

  28. Britton PD, Goud A, Godward S et al (2009) Use of ultrasound-guided axillary node core biopsy in staging of early breast cancer. Eur Radiol 19(3):561–569

    Article  CAS  PubMed  Google Scholar 

  29. Leenders MW, Broeders M, Croese C et al (2012) Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do? Breast 21(4):578–583

    Article  CAS  PubMed  Google Scholar 

  30. Stachs A, Gode K, Hartmann S et al (2013) Accuracy of axillary ultrasound in preoperative nodal staging of breast cancer-size of metastases as limiting factor. Springerplus 2:350

    Article  PubMed Central  PubMed  Google Scholar 

  31. Ganott MA, Zuley ML, Abrams GS et al (2014) Ultrasound guided core biopsy versus fine needle aspiration for evaluation of axillary lymphadenopathy in patients with breast cancer. ISRN Oncol 2014:703160

    PubMed Central  PubMed  Google Scholar 

  32. Fung AD, Collins JA, Campassi C, Ioffe OB, Staats PN (2014) Performance characteristics of ultrasound-guided fine-needle aspiration of axillary lymph nodes for metastatic breast cancer employing rapid on-site evaluation of adequacy: analysis of 136 cases and review of the literature. Cancer Cytopathol 122(4):282–291

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We acknowledge the contributions of all staff, including medical officers, radiologists, pathologists and surgeons working at BreastScreen SA. We acknowledge the contributions of the anonymous reviewers whose suggestions have improved the presentation of this work.

Conflict of interest

None of the authors has declared a conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gelareh Farshid.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Farshid, G., Kollias, J. & Grantley Gill, P. The clinical utility of assessment of the axilla in women with suspicious screen detected breast lesions in the post Z0011 era. Breast Cancer Res Treat 151, 347–355 (2015). https://doi.org/10.1007/s10549-015-3388-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-015-3388-1

Keywords

Navigation